tiprankstipranks
Trending News
More News >
GlaxoSmithKline Pharmaceuticals Limited (IN:GLAXO)
:GLAXO
India Market

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Income Statement

Compare
1 Followers

GlaxoSmithKline Pharmaceuticals Limited Income Statement

Last quarter (Q4 2025), GlaxoSmithKline Pharmaceuticals Limited's total revenue was ₹9.74B, an increase of 4.79% from the same quarter last year. In Q4, GlaxoSmithKline Pharmaceuticals Limited's net income was ₹2.63B. See GlaxoSmithKline Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 37.49B₹ 34.42B₹ 32.52B₹ 32.78B₹ 31.99B
Gross Profit
₹ 23.58B₹ 20.22B₹ 19.67B₹ 18.28B₹ 18.04B
Operating Expenses
₹ 5.80B₹ 7.38B₹ 12.28B₹ 11.30B₹ 11.53B
Depreciation and Amortization
₹ 667.90M₹ 695.36M₹ 656.23M₹ 680.42M₹ 784.61M
EBITDA
₹ 11.77B₹ 8.87B₹ 9.03B₹ 8.49B₹ 5.36B
Operating Income
₹ 17.79B₹ 13.60B₹ 8.39B₹ 7.69B₹ 7.61B
Other Income/Expenses
₹ -5.19B₹ -5.44B₹ -4.03B₹ -3.79B₹ -5.02B
Pretax Income
₹ 12.60B₹ 8.16B₹ 8.36B₹ 7.79B₹ 5.50B
Net Income
₹ 9.28B₹ 5.90B₹ 6.11B₹ 3.81B₹ 3.58B
Per Share Metrics
Basic EPS
₹ 54.76₹ 34.83₹ 36.05₹ 22.48₹ 21.14
Diluted EPS
₹ 54.76₹ 34.83₹ 36.05₹ 22.48₹ 21.14
Weighted Average Shares Outstanding
169.39M 169.41M 169.41M 169.41M 169.41M
Weighted Average Shares Outstanding (Diluted)
169.39M 169.41M 169.41M 169.41M 169.41M
Currency in INR

GlaxoSmithKline Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis